0699T Injection, posterior chamber of the eye, medication This last code goes with Dexycu, which already has an existing code valid for use (J1095)
It may also help with conditions characterized by chronic inflammation or slow recovery times
Fanelli G, Franke B, De Witte W, Ruisch IH, Haavik J, van Gils V, et al
In addition to established efficacy for glycaemic control and weight loss, there has been growing enthusiasm surrounding the cardioprotective effects of GLP-1 agonists, as demonstrated from their superiority to placebo in multiple large studies in preventing major cardiovascular adverse events, namely reduced rates of myocardial infarcts, stroke, and rates of revascularisation procedures (Table 2)